Among the 1068 differentially expressed genes between CRISPRMLL-AF4+ ALL and control CD19+ cells were many genes known to be upregulated in MLL-AF4 ALL, including FLT3, MEIS1, and RUNX1 (Supplementary Fig. 6b). The gene discussed is CD19; the disease is acute lymphoblastic leukemia.